Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism

BACKGROUND: Thrombus formation, a phenomenon primarily related to increased platelet activation, plays a key role in cardiovascular and cerebrovascular diseases. Although the established antiplatelet agents, such as aspirin and clopidogrel, have been shown to be beneficial in treating thromboembolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Ting-Lin, Wu, Ming-Ping, Chung, Chi-Li, Yang, Wen-Bin, Jayakumar, Thanasekaran, Geraldine, Pitchairaj, Chou, Chih-Ming, Chang, Chia-Yau, Lu, Wan-Jung, Sheu, Joen-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756413/
https://www.ncbi.nlm.nih.gov/pubmed/26887315
http://dx.doi.org/10.1186/s12929-016-0245-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756413/
https://www.ncbi.nlm.nih.gov/pubmed/26887315
http://dx.doi.org/10.1186/s12929-016-0245-4

Ejemplares similares